Alright, I know what you’re thinking. What in the world is a mosaic embryo?!
The best way to explain it is by picturing a soccer ball. An embryo is also essentially a ball of cells. A soccer ball is mostly made of white pentagons with some black pentagons here and there. Imagine that the white pentagons are the healthy cells and the black pentagons are the unhealthy or abnormal cells. A mosaic embryo is an embryo with some abnormal cells scattered throughout it.
Does this affect a chance at a successful pregnancy?
The answer is very inconclusive. Recently, the American Society for Reproductive Medicine provided guidelines for the clinical management of mosaic embryos. There have been cases observed where mosaic embryos develop into perfectly healthy fetuses and other cases where the chromosomal abnormalities result in conditions such as Down Syndrome. They also have lower implantation and clinical pregnancy rates. Their developmental potential is approximately 40%, and 40% of mosaic embryos result in pregnancy.
Keep in mind, however, that this largely depends on how many abnormal cells are present in the embryo and the percentage of chromosomes affected. If there are normal embryos available (also called euploid embryos) then those should be given first priority and transferred first as they do have the lowest risk of a miscarriage. It may be easy to avoid using a mosaic embryo if there are other embryos that look like they possess much better potential. However, in the cases where there aren’t many embryos left, or the remaining embryos do not look promising, a mosaic embryo might be what an embryologist thinks is the best chance. Then there are “cutoff mosaic embryos.” These are borderline mosaic and shouldn’t have too much of a problem resulting in successful implantation.
It is often suggested to avoid the transfer of mosaic chromosomes X, Y, 13, 18, 21 and uniparental disomy (UPD) of 7, 14 and 15 as well as, IUGR chromosome 16 because these are often viewed to be risky in the “pure aneuploid (abnormal embryo) form.” However, there is currently no published relationship between embryo pre- implantation mosaicism and detection of mosaicism during prenatal diagnosis.
Image by Andrew Apperley
How can a mosaic embryo result in a successful pregnancy?
Good question! An embryo is constantly growing and that means it’s constantly changing! Those abnormal cells might separate themselves to a part of the tissue that doesn’t really affect the chromosomal development of the embryo and hence not cause any health conditions in the fetus.
What causes a mosaic embryo in the first place?
Mosaicism has been linked to culture conditions, technician effect, and company “threshold”. Age surprisingly does not seem to influence mosaicism. Many infertility issues are often linked to age but mosaicism is not one of them. Even egg donors often provide eggs and lead to mosaic embryos up to 30% of the time.
Are the patients notified of a mosaic embryo?
Yes! There is a step in IVF called the embryo biopsy. It’s when a little sample (a clump of cells) is extracted from the embryo and sent for pre-implantation genetic testing (PGT). This test identifies any genetic abnormalities in the cells of the embryo. If there are abnormal cells identified, then the patients are informed. PGT testing can also provide other information about the embryo that might also help the patients and providers come to a decision about which embryo to transfer.
Interestingly, sometimes PGT provides so much information that it makes it a little harder to decide if the embryo should be transferred or not! What I mean by that is sometimes the samples from one embryo might not agree with each other. There is a part of the embryo called the trophectoderm which is the outer layer. There is then the inner cell mass which is quite self-explanatory: the inner part of the embryo.
Agreement of mosaicism between the two samples is only seen 55% of the time. That means that nearly half of the time, one of those two cell regions demonstrated abnormality while the other doesn’t. Additionally, some PGT labs define mosaicism using a broad range of percentages of cells affected. This range is often 20-80% of cells. If there is ever any noise in the data, this broad range might actually be counterproductive and lead to false-negative and positive results. That simply put-is not good.
Is there a “cut-off” for deeming an embryo a mosaic embryo?
When DNA is sent to a PGT lab, the DNA must be amplified. This means a large number of copies of the sample of DNA are produced. This creates a library of data. When the DNA sequences are being read, there is going to be a minimum placed on reliability of the reading. If the quality of the samples are high, then then the lowest limit of reliability is 20% variance. If the quality of the sample isn’t as high, that limit might go up to 30% variance. With the limit being so low, the process is stricter. For example, if the limit is 20%, and a sample has only 22% variance, it is a mosaic embryo. With lower limits, more embryos are considered mosaic and this process is hence stricter. This limit changes from company to company.
Wrapping it up
To sum it all up, mosaic embryos do tend to have less potential to result in successful pregnancies. Does that mean there is a zero percent chance? No, of course not! We’ve explained earlier how mosaic embryos can result in successful pregnancies. IVF is filled with ups and downs and unexpected surprises! But all in all, if you are told one of your embryos is mosaic, consult with your physician on what you think is the best route to take from there. An IVF cycle requires making many tough decisions, but always remember you are not on your own! Your fertility clinic and physician are rooting for you and will help you make the best decision possible!
Munné S, Blazek J, Large M, Martinez-Ortiz PA, Nisson H, Liu E, Tarozzi N, Borini A, Becker A, Zhang J, Maxwell S, Grifo J, Babariya D, Wells D, Fragouli E.
Fertil Steril. 2017 Jul;108(1):62-71.e8. doi: 10.1016/j.fertnstert.2017.05.002. Epub 2017 Jun 1.
Fragouli E, Alfarawati S, Spath K, Babariya D, Tarozzi N, Borini A, Wells D.
Hum Genet. 2017 Jul;136(7):805-819. doi: 10.1007/s00439-017-1797-4. Epub 2017 Apr 9.
Greco E, Minasi MG, Fiorentino F.N Engl J Med. 2015 Nov 19;373(21):2089-90. doi: 10.1056/NEJMc1500421. No abstract available.